Under the pressure of centralized procurement, the demand for pharmaceutical equipment of pharmaceutical companies will continue to expand

[ Focus on Chemical Machinery and Equipment Network ] In recent years, with the continuous implementation of centralized drug procurement, the pressure of competition for ordinary generic drugs has increased, and they have gradually fallen into the fierce market competition of homogenization and low-end.
In addition, in the context of the accelerated implementation of the centralized procurement expansion policy, the winning products and the non-successful products are also beginning to face the pressure of lowering prices.
In this regard, the industry believes that, in the context of falling domestic drug prices and rising production costs and labor costs of pharmaceutical companies, controlling costs and ensuring drug quality and safety will increasingly become major challenges in the development of pharmaceutical companies.

It is understood that in order to cope with the increasing pressure of centralized procurement, a large number of pharmaceutical companies are currently accelerating the transformation to generic drugs and innovative drugs.
For a time, the upsurge of chasing innovation has begun to emerge in the industry.
However, for the innovative research and development of such drugs, some people in the industry have pointed out that they will encounter many difficult problems in the research and development process, such as the problem of excipients and the difficulty of BA/BE.
In addition, changes in process parameters have a great impact on the quality of finished products.
Compared with ordinary generic drugs, pharmaceutical companies will have higher requirements for the functions and control accuracy of pharmaceutical equipment .
Affected by this, the industry expects that the demand for pharmaceutical equipment from pharmaceutical companies will continue to expand in the future.

 

*, pharmaceutical equipment is an indispensable tool and equipment for pharmaceutical production, and is the "heart" and "engine" of the pharmaceutical industry.
The performance, functions, and precision of pharmaceutical equipment will directly affect the quality of pharmaceuticals.
Therefore, in order to better promote the transformation of pharmaceutical companies to generic drugs and innovative drugs, the industry believes that the pharmaceutical equipment industry also needs continuous innovation to introduce new ones.
Equipment to meet new market demands.

 

According to the author’s understanding, in recent years, with the continuous promulgation of national favorable policies and the hard work of the pharmaceutical equipment industry, in fact, my country’s pharmaceutical equipment technology has achieved greater breakthroughs, including Chutian Technology, Tofflon, and Canaan Technology as representatives.
China's pharmaceutical equipment industry is now assuming the responsibility of realizing domestic substitution of imports, and some products and equipment have even caught up.
Advance the level.
This actually brings strong equipment support to the pharmaceutical industry.

 

However, it is worth noting that, according to the actual development of domestic pharmaceutical equipment products, companies still need to work from the following aspects to further help pharmaceutical companies improve production efficiency and achieve high-quality, low-cost development.
First of all, pharmaceutical equipment companies should continue to optimize equipment to help achieve the goal of "energy saving and quality improvement".
It is reported that in recent years, with the continuous development of my country's pharmaceutical industry, the requirements for equipment energy conservation are constantly increasing, and the demand for energy-saving and environmentally-friendly pharmaceutical equipment by pharmaceutical companies is also continuing to grow.

 

Secondly, domestic pharmaceutical equipment companies should also increase investment in research and development of automation and intelligent technologies.
It is understood that a production line with a complete structure and complete technology will help improve the production quality and production speed of medicines.
In recent years, under the background of continuous advancement of science and technology, in order to improve efficiency and further guarantee the quality of medicines, intelligent and fully automatic production lines are beginning to be widely used in the pharmaceutical production process.
Some pharmaceutical companies have even begun to adopt "machines".
The "substitution" model is realizing mechanized operations, continuously improving the quality of pharmaceutical production, and reducing costs at the same time.

 

　　In addition, pharmaceutical equipment companies should closely follow customer needs and market development trends to upgrade their products.
Pharmaceutical equipment companies need to pay attention to R&D investment in technological innovation in terms of products, such as further research and development of product usage requirements based on customer experience, and launch products that are more in line with customer needs.

 

　　In fact, under the implementation of policies such as centralized procurement, consistency evaluation, and the new version of GMP, pharmaceutical companies have begun to drive the annual output value of the entire pharmaceutical equipment industry while the demand for pharmaceutical equipment has soared in order to meet higher production requirements.
.
According to statistics, in the five years from 2011 to 2015, the annual output value of my country's pharmaceutical equipment industry has increased from 8.
96 billion yuan to 20.
19 billion yuan in 2015, breaking the 20 billion mark, with a five-year compound growth rate of 34%.
In addition, according to data released by the China Pharmaceutical Equipment Industry Association, the overall sales revenue of China's pharmaceutical equipment industry also showed an increasing trend from 2015 to 2018.
In 2015, sales revenue was 23.
9 billion yuan; in 2018, sales revenue was 33.
7 billion yuan, an increase of 14.
2% from 2017.

 

　　The industry believes that from the above data and industry development analysis, with the normalization of policies such as volume procurement, it will be good for the pharmaceutical equipment industry as a whole.
Under the background that mass-purchasing products are about to benefit patients across the country and normalization has become a trend, pharmaceutical equipment will play an increasingly critical role in ensuring drug production.
Relevant pharmaceutical equipment companies need to deepen cooperation with pharmaceutical companies, maintain more in-depth exchanges, and strengthen R&D investment in order to create new equipment and new technologies that are more in line with the real needs of pharmaceutical companies and usher in a broader market.

 

　　Original title: Under the pressure of centralized procurement, the demand for pharmaceutical equipment of pharmaceutical companies will continue to expand